| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Board Observer
1 company
Abraham Chesed last filed a Form 4 in October 2025, as Board Observer at TTRX. Abraham Chesed's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,447,268 shares of TTRX. Net of sales, the TTRX filings show accumulation of 14,286 shares.
Abraham Chesed has 1 Form 4 filing on record in October 2025, as Board Observer at Turn Therapeutics (TTRX), 2025.
The 1 reported transaction was 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $66K and no sales.
The only open-market purchase was 14,286 shares of TTRX at an average $4.60 on October 23, 2025, about $66K. Twelve months later TTRX was up 108%.
Shares as reported in the last Form 4 for each company; the most recent is from October 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | TTRX Turn Therapeutics Inc. | Board Observer | Buy | 14,286 | $4.60 | $65,715.60 | +1.0% | -6.3% | +107.7% |